Clinical Trial Update: Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer [NA]

View source ↗

Summary

A clinical trial update indicates recruitment for a study of Sacituzumab Govitecan in combination with immunotherapy for advanced thyroid cancers, including rad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Poorly Differentiated Thyroid Carcinoma
• Radioiodine-refractory Differentiated Thyroid Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Advanced Thyroid Carcinoma, Radioiodine-refractory Differentiated Thyroid Cancer | NA | Status: RECRUITING